LifeVantage (NASDAQ:LFVN) Stock Rating Upgraded by ValuEngine

ValuEngine upgraded shares of LifeVantage (NASDAQ:LFVN) from a sell rating to a hold rating in a report issued on Tuesday morning, ValuEngine reports.

NASDAQ LFVN opened at $15.09 on Tuesday. The firm’s 50-day moving average is $14.53 and its two-hundred day moving average is $12.74. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.67 and a quick ratio of 1.09. LifeVantage has a 12 month low of $10.62 and a 12 month high of $17.08. The stock has a market capitalization of $210.67 million, a P/E ratio of 25.58 and a beta of 0.64.

LifeVantage (NASDAQ:LFVN) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.13 EPS for the quarter, topping the consensus estimate of $0.12 by $0.01. LifeVantage had a return on equity of 38.13% and a net margin of 3.65%. The business had revenue of $56.23 million during the quarter. As a group, analysts anticipate that LifeVantage will post 0.67 EPS for the current year.

In other LifeVantage news, CEO Darren Jay Jensen sold 4,500 shares of the firm’s stock in a transaction that occurred on Wednesday, November 20th. The shares were sold at an average price of $14.13, for a total value of $63,585.00. Following the completion of the transaction, the chief executive officer now owns 411,470 shares of the company’s stock, valued at approximately $5,814,071.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 6.80% of the stock is owned by corporate insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of LFVN. Acadian Asset Management LLC increased its position in shares of LifeVantage by 14.7% in the 2nd quarter. Acadian Asset Management LLC now owns 418,294 shares of the company’s stock valued at $5,430,000 after purchasing an additional 53,545 shares during the last quarter. Vanguard Group Inc. increased its holdings in LifeVantage by 4.8% in the second quarter. Vanguard Group Inc. now owns 665,728 shares of the company’s stock valued at $8,641,000 after buying an additional 30,342 shares during the last quarter. BlackRock Inc. increased its holdings in LifeVantage by 237.4% in the second quarter. BlackRock Inc. now owns 891,174 shares of the company’s stock valued at $11,568,000 after buying an additional 627,070 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. raised its stake in LifeVantage by 21.6% in the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 46,104 shares of the company’s stock valued at $598,000 after buying an additional 8,175 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. raised its stake in LifeVantage by 214.7% in the second quarter. Jacobs Levy Equity Management Inc. now owns 117,545 shares of the company’s stock valued at $1,526,000 after buying an additional 80,199 shares in the last quarter. Institutional investors own 45.15% of the company’s stock.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio, a line of energy drink mixes; Omega+, a fish oil dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to treat oxidative stress in dogs.

Read More: Why do companies issue stock splits?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit